Enject, Inc.

Description

Daniel has more than 20 years of commercial and line management experience in big pharma companies and subsequently with early-stage biotech companies in board, strategic, product development, and business development roles. He was the founding CEO and President of DiObex, a company focused on metabolic diseases (such as Diabetes), and raised in excess of $30 million in venture financing while shepherding 2 products into advanced clinical development.

Companies nearby